HomeABUS • NASDAQ
add
Arbutus Biopharma Corp
$4.15
Makalipas ang Oras ng Trabaho:(0.24%)-0.010
$4.14
Sarado: Okt 18, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$4.12
Sakop ng araw
$4.11 - $4.19
Sakop ng taon
$1.69 - $4.72
Market cap
783.45M USD
Average na Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.73M | -62.89% |
Gastos sa pagpapatakbo | 21.98M | -3.15% |
Net na kita | -19.80M | -15.81% |
Net profit margin | -1.15K | -212.06% |
Kita sa bawat share | -0.15 | -14.22% |
EBITDA | -21.02M | -12.51% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 141.99M | -6.88% |
Kabuuang asset | 160.04M | -9.49% |
Kabuuang sagutin | 37.59M | -10.78% |
Kabuuang equity | 122.45M | — |
Natitirang share | 188.78M | — |
Presyo para makapag-book | 6.34 | — |
Return on assets | -34.43% | — |
Return on capital | -42.30% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -19.80M | -15.81% |
Cash mula sa mga operasyon | -14.50M | 25.84% |
Cash mula sa pag-invest | 9.83M | 582.10% |
Cash mula sa financing | 24.37M | 413.92% |
Net change in cash | 19.69M | 247.17% |
Malayang cash flow | -7.10M | 31.18% |
Tungkol
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
73
